Business Context and Reporting Period
This Form 8-K, filed August 9, 2022, was filed by Pono Capital Two, Inc., a Delaware special purpose acquisition company. The provided filing does not identify SBC Medical Group Holdings Inc. as the registrant. The report covers the closing of Pono Capital Two’s initial public offering and related transactions on August 9, 2022, with the underwriting agreement entered into August 4, 2022.
Key Financial Metrics and Capitalization
| Item | Reported amount or terms |
|---|---|
| Public offering | 11,500,000 units at $10.00 per unit, including the underwriters’ full exercise of the 1,500,000-unit over-allotment option |
| Gross public offering proceeds | $115.0 million, consisting of the initial $100.0 million offering plus $11.50 million from the over-allotment option |
| Private placement | 634,375 units sold to the sponsor at $10.00 per unit |
| Gross private placement proceeds | $6.34375 million |
| Trust account funding | $117.875 million placed in a U.S.-based trust account, net of underwriting commissions, discounts and offering expenses |
| Warrant terms | Each public unit includes one redeemable warrant exercisable for one Class A common share at $11.50 per share |
The filing does not provide revenue, operating profit, net income, cash flow, margins, debt balances, or conventional liquidity ratios. It describes an offering and SPAC trust structure rather than operating results.
Material Changes Versus the Prior Comparable Period
No prior comparable financial period or operating results are presented. The material changes disclosed are the completion of the initial public offering, the full exercise of the over-allotment option, the sponsor’s private placement, and the placement of proceeds into the trust account.
Guidance, Outlook, Risks, Contingencies and Unusual Items
- The trust account is generally restricted until the earliest of the completion of an initial business combination, specified redemptions, or the company’s failure to complete a business combination within the applicable deadline.
- The stated deadline is nine months from the offering closing, subject to extension to as long as 18 months under the amended charter or as otherwise approved by stockholders.
- If no business combination is completed within the applicable period, public shares are subject to redemption, subject to applicable law and the charter’s terms.
- Interest earned on the trust funds may be released to pay taxes, with up to $100,000 of interest available for dissolution expenses.
- The private placement units and their component securities generally cannot be transferred, assigned or sold until 30 days after completion of the initial business combination, except to permitted transferees.
- No management revenue or earnings guidance is provided. The principal future uncertainty is the identification and completion of an initial business combination.
Important Facts for Investors to Verify
- Confirm the correct registrant: the filing identifies Pono Capital Two, Inc., not SBC Medical Group Holdings Inc.
- Verify the final trust account balance, including the impact of underwriting discounts, commissions and offering expenses.
- Review the amended charter for the precise business-combination deadline, extension provisions and redemption mechanics.
- Review the underwriting agreement, warrant agreement, sponsor arrangements and registration rights for dilution, transfer restrictions and potential conflicts.
- Confirm the terms and timing of any eventual initial business combination and any related shareholder redemption rights.